Stephanie Monaghan O’Brien Esq.
Investment Professional,Morningside Ventures
|Age||Total Calculated Compensation||This person is connected to 63 board members in 5 different organizations across 6 different industries.|
See Board Relationships
Ms. Stephanie Monaghan O’Brien, Esq., serves as an Executive Officer of Morningside Technologies. Ms. O’Brien worked in international portfolio analysis at Chase Manhattan Bank, N.A. She spent nine years as a Corporate Lawyer with Hale and Dorr in both the Boston and Washington. She has been a Director of Aduro BioTech, Inc. since 2011 and serves its Lead Independent Director. She served as a Director at Alacer Biomedical Inc., I-Behavior Inc., BiddingForGood Inc., Inimex ...
22nd FloorPhone: 852 2894 9800
Causeway Bay, -- --
Fax: 852 2577 3509
Board Members Memberships*
Lead Independent Director
Director, Chairman of Compensation Committee and Member of Audit Committee
New York University School Of Law
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|There is no Competitor Compensation data available.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.